Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed… Read More
How pandemic-driven talent migration will change where biotech companies are located Joel Marcus’ fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria… Read More
